These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 28138221)
1. Immunotherapy for the treatment of colorectal tumors: focus on approved and in-clinical-trial monoclonal antibodies. Françoso A; Simioni PU Drug Des Devel Ther; 2017; 11():177-184. PubMed ID: 28138221 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review. Tol J; Punt CJ Clin Ther; 2010 Mar; 32(3):437-53. PubMed ID: 20399983 [TBL] [Abstract][Full Text] [Related]
3. Integration of novel agents in the treatment of colorectal cancer. Iqbal S; Lenz HJ Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S32-9. PubMed ID: 15309512 [TBL] [Abstract][Full Text] [Related]
4. Development of monoclonal antibodies for the treatment of colorectal cancer. Goodin S Am J Health Syst Pharm; 2008 Jun; 65(11 Suppl 4):S3-7; quiz S22-4. PubMed ID: 18499888 [TBL] [Abstract][Full Text] [Related]
5. The safety of monoclonal antibodies for treatment of colorectal cancer. Berger MD; Lenz HJ Expert Opin Drug Saf; 2016 Jun; 15(6):799-808. PubMed ID: 26982510 [TBL] [Abstract][Full Text] [Related]
6. Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategies. Mauri G; Pizzutilo EG; Amatu A; Bencardino K; Palmeri L; Bonazzina EF; Tosi F; Carlo Stella G; Burrafato G; Scaglione F; Marsoni S; Siravegna G; Bardelli A; Siena S; Sartore-Bianchi A Cancer Treat Rev; 2019 Feb; 73():41-53. PubMed ID: 30616224 [TBL] [Abstract][Full Text] [Related]
7. Panitumumab a novel drug in cancer treatment. Cartenì G; Fiorentino R; Vecchione L; Chiurazzi B; Battista C Ann Oncol; 2007 Jun; 18 Suppl 6():vi16-21. PubMed ID: 17591813 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of approved monoclonal antibody therapy for colorectal cancer. Saoudi Gonzalez N; López D; Gómez D; Ros J; Baraibar I; Salva F; Tabernero J; Élez E Expert Opin Drug Metab Toxicol; 2022 Nov; 18(11):755-767. PubMed ID: 36582117 [TBL] [Abstract][Full Text] [Related]
9. [Molecular target therapy and chemotherapy for advanced colorectal cancer]. Nakashima K; Yamazaki K; Boku N Gan To Kagaku Ryoho; 2008 May; 35(5):725-30. PubMed ID: 18487907 [TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor monoclonal antibodies for the treatment of metastatic colorectal cancer. Jean GW; Shah SR Pharmacotherapy; 2008 Jun; 28(6):742-54. PubMed ID: 18503402 [TBL] [Abstract][Full Text] [Related]
11. Overview of monoclonal antibodies and small molecules targeting the epidermal growth factor receptor pathway in colorectal cancer. Snyder LC; Astsaturov I; Weiner LM Clin Colorectal Cancer; 2005 Nov; 5 Suppl 2():S71-80. PubMed ID: 16336752 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies targeting vascular endothelial growth factor: current status and future challenges in cancer therapy. Hsu JY; Wakelee HA BioDrugs; 2009; 23(5):289-304. PubMed ID: 19754219 [TBL] [Abstract][Full Text] [Related]
19. Anti-EGFR monoclonal antibodies for treatment of colorectal cancers: development of cetuximab and panitumumab. You B; Chen EX J Clin Pharmacol; 2012 Feb; 52(2):128-55. PubMed ID: 21427284 [TBL] [Abstract][Full Text] [Related]